Skip to main content
SpringerLink
Log in

Guidelines for Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

  • Protocol
Anticoagulants, Antiplatelets, and Thrombolytics

Part of the book series: Methods In Molecular Medicine™ ((MIMM,volume 93))

  • 590 Accesses

Abstract

Venous thromboembolism (VTE) is a term that includes both deep venous thrombosis (DVT) and pulmonary embolism (PE). Considerable progress has been made in the understanding of the risk factors for VTE. The clinical applications of molecular techniques have facilitated identification of important inherited, yet not uncommon risk factors for VTE. Factor V Leiden (1–5) and prothrombin G20210A mutation (6–10) are among the most common. Such progress raised many questions regarding the need for and duration of anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bertina, R. M., Koeleman, R. P. C, Koster, T., Rosendaal, F. R., Dirven, R. J., De Ronde, H., et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64–67.

    Article  PubMed  CAS  Google Scholar 

  2. Rees, D. C, Cox, M., and Clegg, J. B. (1995) World distribution of factor V Leiden. Lancet 346, 1133–1134.

    Article  PubMed  CAS  Google Scholar 

  3. Svensson, P. J. and Dahlback, B. (1994) Resistance to activated protein C as a basis for venous thrombosis. N. Engl. J. Med. 330, 517–522.

    Article  PubMed  CAS  Google Scholar 

  4. Koster, T., Rosendaal, F R., de Ronde, H., Briet, E., Vandenbroucke, J. P., and Bertina, R. M. (1993) Venous thrombosis due to a poor anticoagulant response to activated protein C: leiden thrombophilia study. Lancet 342, 1503–1506.

    Article  PubMed  CAS  Google Scholar 

  5. Rosendaal, F. R., Koster, T., Vandenbroucke, J. P., and Reitsma, P. H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85, 1504–1508.

    PubMed  CAS  Google Scholar 

  6. Kyrle, P. A., Mannhalter, C., Beguin, S., Stumpflen, A., Hirschl, M., Weltermann, A., et al. (1998) Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler. Thromb. Vase. Biol. 18, 1287–1291.

    Article  CAS  Google Scholar 

  7. Rosendaal, F. R., Doggen, C. J. M., Zivelin, A., Arruda, V. R., Aiach, M., Siscovick, D. S., et al. (1998) Geographic distribution of the 20210G to A prothrombin variant. Thromb. Haemostasis 79, 706–708.

    CAS  Google Scholar 

  8. Hillarp, A., Zoller, B., Svensson, P. J., and Dahlback, B. (1997) The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb. Haemostasis 78, 990–992.

    CAS  Google Scholar 

  9. Leroyer, C., Mercier, B., Oger, E., Chenu, E., Abgrall, J. F., Ferec, C., et al. (1998) Prevalence of the 202a0A allele of the prothrombin gene in venous thromboembolism patients. Thromb. Haemostasis 80, 49–51.

    CAS  Google Scholar 

  10. Margaglione, M., Brancaccio, V., Guiliani, N., D’Andrea, G., Cappucci, G., Iannaccone, L., et al. (1998) Increased risk for venous thrombosis in carriers of the prothrombin G20210A gene variant. Ann. Intern. Med. 129, 89–93.

    PubMed  CAS  Google Scholar 

  11. Merli, G., Spiro, T. E., Olsson, G. C., et al. (2001) Subcutaneous Enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolitic disease. Ann. Intern. Med. 134, 191–202.

    PubMed  CAS  Google Scholar 

  12. The Columbus Investigators (1997) Low-molecular-weight heparin in the treatment of patient with venous thromboembolism. N. Engl. J. Med. 337, 657–662.

    Article  Google Scholar 

  13. Finazzi, G. and Barbui, T. (1994) Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S. Thromb. Haemostasis 71, 15–18.

    CAS  Google Scholar 

  14. Demers, C., Ginsberg, J. S., Hirsh, J., Henderson, P., and Blajchman, M. A. (1992) Thrombosis in antithrombin III-deficient persons: report of a large kindred and literature review. Ann. Intern. Med. 116, 754–761.

    PubMed  CAS  Google Scholar 

  15. Tait, R. C., Walker, I. D., Perry, D. J., Islam, S. I., Daly, M. E., McCall, F., et al. (1994) Prevalence of antithrombin deficiency in the healthy population. Br. J. Haematol. 87, 106–112.

    Article  PubMed  CAS  Google Scholar 

  16. Tait, R. C., Walker, I. D., Reitsma, P. H., Islam, S. I., McCall, F., Poor, S. R., et al. (1995) Prevalence of protein C deficiency in the healthy population. Thromb. Haemostasis 73, 87–93.

    CAS  Google Scholar 

  17. Griffin, J. H., Evatt, B., Zimmerman, T. S., Kleiss, A. J., and Wideman, C. (1981) Deficiency of protein C in congenital thrombotic disease. J. Clin. Invest. 68, 1370–1373.

    Article  PubMed  CAS  Google Scholar 

  18. Broekmans, A. W., Veltkamp, J. J., and Bertina, R. M. (1983) Congenital protein C deficiency and venous thromboembolism: a study of three Dutch families. N. Engl. J. Med. 309, 340–344.

    Article  PubMed  CAS  Google Scholar 

  19. Schwarz, H. P., Fischer, M., Hopmeier, P., Batard, M. A., and Griffin, J. H. (1984) Plasma protein S deficiency in familial thrombotic disease. Blood 64, 1297–1300.

    PubMed  CAS  Google Scholar 

  20. Sanson, B. J., Simioni, P., Tormene, D., Moia, M., Friederick, P. W., Huisman, M. V., et al. (1999) The incidence of venous thromboembolism in asymptomatic carriers of deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood 94, 3702–3706.

    PubMed  CAS  Google Scholar 

  21. Haverkate, F. and Samama, M. (1995) Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on fibrinogen. Thromb. Haemostasis 73, 151–161.

    CAS  Google Scholar 

  22. Cattaneo, M. (1999) Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb. Haemostasis 81, 165–176.

    CAS  Google Scholar 

  23. Falcon, C. R., Cattaneo, M., Panzeri, D., Martinelli, I., and Mannucci, P. M. (1994) High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler. Thromb. 14, 1080–1083.

    Article  PubMed  CAS  Google Scholar 

  24. Ridker, P. M., Hennekens, C. H., Selhub, J., Miletich, J. P., Malinow, M. R., and Stampfer, M. J. (1997) Interrelation of hyperhomocyt(e)inemia, factor V Leiden, and the risk of future venous thromboembolism. Circulation 95, 1777–1782.

    PubMed  CAS  Google Scholar 

  25. Koster, T., Blann, A. D., Briet, E., Vandenbroucke, J. P., and Rosendaal, F. R. (1995) Role of clotting factor VIII in effect of von Willebrand factor an occurrence of deepvein thrombosis. Lancet 345, 152–155.

    Article  PubMed  CAS  Google Scholar 

  26. O’Donnell, J., Tuddenham, E. G., Manning, R., Kemball-Cook, G., Johnson, D., and Laffan, M. (1997) High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to acute phase reaction. Thromb. Haemostasis 77, 825–828.

    Google Scholar 

  27. Kraaijenhagen, R. A., in’t Anker, P. S., Koopman, M. M., Reitsma, P. H., Prins, M. H., van den Ende, A., et al. (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb. Haemostasis 83, 5–9.

    CAS  Google Scholar 

  28. O’Donnell, J., Mumford, A. D., Manning, R. A., and Laffan, M. (2000) Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response. Thromb. Haemostasis 83, 10–13.

    Google Scholar 

  29. Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., et al. (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N. Engl. J. Med. 343, 457–462.

    Article  PubMed  CAS  Google Scholar 

  30. van Hylckama, V. A., van der Linden, I. K., Bertina, R. M., and Ronsendaal, F. R. (2000) High levels of factor IX increase the risk of venous thrombosis. Blood 95, 3678–3682.

    Google Scholar 

  31. Meijers, C. M. J., Tekelenburg, L. H. W., Bouma, N. B., Bertina, R. M., and Rosendaal, F. R. (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. N. Engl. J. Med. 343, 696–701.

    Article  Google Scholar 

  32. Zoller, Svensson, P. J., He, X., and Dahlback, B. (1994) Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J. Clin. Invest. 94, 2521–2524.

    Article  PubMed  CAS  Google Scholar 

  33. Bernardi, F., Faioni, E. M., Castoldi, E., Lunghi, B., Castaman, G., Sacchi, E., et al. (1997) A factor V genetic component differing from factor V R506Q contributed to the activated protein C resistance phenotype. Blood 90, 1552–1557.

    PubMed  CAS  Google Scholar 

  34. Williamson, D., Brown, K., Luddington, R., Baglin, C., and Baglin, T. (1998) Factor V Cambridge: a new mutation (Arg306®Thr) associated with resistance to activated protein C. Blood 91, 1140.4.

    PubMed  Google Scholar 

  35. Nordstrom, M., Lindblad, B., Bergqvist, D., and Kjellstrom, T. (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J. Intern. Med. 232, 155–160.

    Article  PubMed  CAS  Google Scholar 

  36. Anderson, F A., Wheeler, H. G., Goldberg, R. J., Hosmer, D. W., Patwardhan, N. A., Jovanovic, B., et al. (1991) A population based perspective of the hospital incidence and case-fatality rates deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch. Intern. Med. 151, 933–938.

    Article  PubMed  Google Scholar 

  37. Ridker, P. M., Glynn, R. J., Miletich, J. P., Goldhaber, S. Z., Stampfer, M. J., and Hennekens, C. H. (1997) Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann. Intern. Med. 126, 528–531.

    PubMed  CAS  Google Scholar 

  38. Ginsberg, J. S., Wells, P. S., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., et al. (1995) Antiphospholipid antibodies and venous thromboembolism. Blood 86, 3685–3691.

    PubMed  CAS  Google Scholar 

  39. Simioni, P., Prandoni, P., Zanan, E., Saracino, M. A., Scudeller, A., Villalta, S., et al. (1986) Deep venous thrombosis and lupus anticoagulant. Thromb. Haemostasis 76, 187–189.

    Google Scholar 

  40. Geerts, W. H., Code, K. I., Jay, R. M., Chen, E., and Szalai, J. P. (1994) A prospective study of venous thromboembolism after major trauma. N. Engl. J. Med. 331, 1601–1606.

    Article  PubMed  CAS  Google Scholar 

  41. Geerts, W. H., Jay, R. M., Code, K. I., Chen, E., Szalai, J. P., Saibil, E. A., et al. (1996) A comparison of low-dose heparin with low molecular weight heparin as prophylaxis against venous thromboembolism after major trauma. N. Engl. J. Med. 335, 701–707.

    Article  PubMed  CAS  Google Scholar 

  42. Prandoni, P., Lensing, A. W. A., Buller, H. R., Cogo, A., Prins, M. H., Cattelan, A. M., et al. (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N. Engl. J. Med. 327, 1128–1133.

    Article  PubMed  CAS  Google Scholar 

  43. Monreal, M., Lafoz, E., Casals, A., Inaraja, L., Montserrat, E., Callejas, J. M., et al. (1991) Occult cancer in patients with deep venous thrombosis. Cancer 67, 541–545.

    Article  PubMed  CAS  Google Scholar 

  44. Cornuz, J., Pearson, S. D., Creager, M. A., Cook, E. F., and Goldman, L. (1996) Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann. Intern. Med. 125, 785–793.

    PubMed  CAS  Google Scholar 

  45. Piccioli, A., Prandoni, P., Ewenstein, B. M., and Goldhaber, S. Z. (1996) Cancer and venous thromboembolism. Am. Heart J. 132, 850–855.

    Article  PubMed  CAS  Google Scholar 

  46. Goldberg, R. J., Seneff, M., Gore, J. M., Anderson, F. A., Jr., Greene, H. L., Wheeler, H. B., et al. (1987) Occult malignant neoplasm in patients with deep venous thrombosis. Arch. Intern. Med. 147, 251–253.

    Article  PubMed  CAS  Google Scholar 

  47. Hettiarachchi, R. J., Lok, J., Prins, M. H., Buller, H. R., and Prandoni, P. (1998) Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. Cancer 83, 180–185.

    Article  PubMed  CAS  Google Scholar 

  48. Sorensen, H. T., Mellemkjaer, L., Steffenssen, F. H., Olsen, J. H., and Nielsen, G. L. (1998) The risk of diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N. Engl. J. Med. 338, 1169–1173.

    Article  PubMed  CAS  Google Scholar 

  49. Clagett, G. P. (1994) Prevention of postoperative venous thromboembolism: an update. Am. J. Surg. 168, 515–522.

    Article  PubMed  CAS  Google Scholar 

  50. Hull, R. D. and Raskob, G. E. (1986) Prophylaxis of venous thromboembolic disease following hip and knee surgery. J. Bone Jt. Surg. 68, 146–150.

    CAS  Google Scholar 

  51. Gibbs, N. M. (1957) Venous thrombosis of the lower limbs with particular reference to bed rest. Br. J. Surg. 54, 209.

    Article  Google Scholar 

  52. Sigel, B., Ipse, J., and Felix, W. R. (1974) The epidemiology of lower extremity deep venous thrombosis in surgical patient. Ann. Surg. 179–278.

    Google Scholar 

  53. Hull, R., Delmore, T, Carter, C, Hirsh, J., Genton, E., Gen, M.. et al. (1982) Adjusted subcutaneous heparin versus Warfarin sodium in the long-term treatment of venous thrombosis. N. Engl. J. Med. 306, 189–194.

    Article  PubMed  CAS  Google Scholar 

  54. Andersen, B. S., Steffensen, F. H., Sorensen, H. T., Nielsen, G. L., and Olsen, J. (1998) The cumulative incidence of venous thromboembolism during pregnancy and puerperium. Acta Obstet. Gynecol. Scand. 77, 170–173.

    Article  PubMed  CAS  Google Scholar 

  55. Lindqvist, P., Dahlback, B., and Marsal, K. (1999) Thrombotic risk during pregnancy: a population study. Obstet. Gynecol. 94, 595–59.

    Article  PubMed  CAS  Google Scholar 

  56. Treffers, P. E., Huidekoper, B. L., Weenink, G. H., and Kloosterman, G. J. (1983) Epidemiological observations of thromboembolic disease during pregnancy and in the puerperium, in 56,022 women. Int. J. Gynaecol. Obstet. 21, 327–331.

    Article  PubMed  CAS  Google Scholar 

  57. Ray, J. G. and Chan, W. S. (1999) Deep vein thrombosis during pregnancy and the puerperium. Obstet. Gynecol. Surv. 54, 265–271.

    Article  PubMed  CAS  Google Scholar 

  58. Gerstmann, B. B., Piper, J. M. Tomita, D. K., Ferguson, W. J., Stadel, B. V., and Lundin, F. E. (1991) Oral contraceptive estrogen dose and the risk for deep venous thromboembolic disease. Am. J. Epidemiol. 133, 32–37.

    Google Scholar 

  59. Helmerhorst, F. M., Bloemenkamp, K. W., Rosendaal, F. R., and Vandenroucke, J. P. (1997) Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thromb. Haemostasis 78, 327–333.

    CAS  Google Scholar 

  60. WHO Study Group (1995) Effect of different progestagens in low estrogen oral Contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 346, 1582–1588.

    Google Scholar 

  61. Spitzer, W. O., Lewis, M. A., Heinemann, L. A., Thorogood, M., and Mac Rae, K. D. (1996) Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Br. Med. J. 312, 83–88.

    Google Scholar 

  62. Farmer, R. D., Lawrenson, R. A., Thompson, C. R., Kennedy, J. G., and Hambleton, I. R. (1997) Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 349, 83–88.

    Article  PubMed  CAS  Google Scholar 

  63. Bloemenkamp, K. W., Rosendaal, F. R., Helmerhorst, F. M., Buller, H. R., Colly, L. P., and Vandenbroucke, J. P. (1999) The association between oral contraceptives and venous thrombosis: the myth of the diagnostic suspicion and referral bias. Arch. Intern. Med. 159, 65–70.

    Article  PubMed  CAS  Google Scholar 

  64. Perrier, A., Desmarais, S., Miron, M. J., de Moerloose, P., Lepage, R., Slosman, D., et al. (1999) Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 353, 190–195.

    Article  PubMed  CAS  Google Scholar 

  65. Bounameaux, H., de Moerloose, P., Perrier, A., and Miron, M. J. (1997) D-dimer testing in suspected venous thromboembolism: an update. QJM 90, 437–442.

    Article  PubMed  CAS  Google Scholar 

  66. Becker, D. M., Philbrick, J. T, Bachhuber, T. L., and Humphries, J. E. (1996) D-dimer testing and acute venous thromboembolism. A shortcut to accurate diagnosis? Arch. Intern. Med. 156, 939–946.

    Article  PubMed  CAS  Google Scholar 

  67. Janssen, M. C., Wollersheim, H., Verbruggen, B., and Novakova, I. R. (1998) Rapid D-dimer assays to exclude deep venous thrombosis and pulmonary embolism: current status and new developments. Semin. Thromb. Hemost. 24, 393–400.

    Article  PubMed  CAS  Google Scholar 

  68. Borg, J. Y., Levesque, H., Cailleux, N., Franc, C., Hellot, M. F., and Courtois, H. (1997) Rapid quantitative D-dimer assay and clinical evaluation for the diagnosis of clinical suspected deep vein thrombosis. Thromb. Haemostasis 77, 602–603.

    CAS  Google Scholar 

  69. Becker, D. M., Philbrick, J. T., and Abbitt, P. L. (1989) Real-time ultrasonography for the diagnosis of lower extremity deep venous thrombosis. The wave of the future? Arch. Intern. Med. 149, 173–174.

    Article  Google Scholar 

  70. Lensing, A. W. A., Pandoni, P., Brandjes, D., Huisman, P. M., Vigo, M., Tomasella, G., et al. (1989) Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N. Engl. J. Med. 320, 342–345.

    Article  PubMed  CAS  Google Scholar 

  71. Cogo, A., Lensing, A. W. A., Koopman, M. M. W., Piovella, F., Siragusa, S., Wells, P. S., et al. (1998) Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. The Multicenter Italian D-dimer Ultrasound Study Investigators Group. BMJ 317, 1037–1040.

    Article  Google Scholar 

  72. Kearon, C., Ginsberg, J. S., and Hish, J. (1998) The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann. Intern. Med. 129, 1044–1049.

    PubMed  CAS  Google Scholar 

  73. Cogo, A., Lensing, A. W. A., Koopman, M. M. W., Piovella, F., Siragusa, S., Wells, P. S., et al. (1998) Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. The Multicentre Italian D-dimer Ultrasound Study Investigators Group. BMJ 317, 1037–1040.

    Article  Google Scholar 

  74. Wells, P. S., Hirsh, J., Andreson, D. R., Lensing, A. W., Foster, G., Kearon, C, et al. (1995) Accuracy of clinical assessment of deep vein thrombosis. Lancet 345, 1326–1330.

    Article  PubMed  CAS  Google Scholar 

  75. Wells, P. S., Hirsch, J., Anderson, D. R., Lensing, A. W., Foster, G., Kearon, C, et al. (1995) Accuracy of clinical assessment of deep-vein thrombosis. Lancet 345, 1326–1330.

    Article  PubMed  CAS  Google Scholar 

  76. Anderson, D. R., Lensing, A. W. A., Wells, P. S., Levine, M. N., Weitz, J. R., and Hirsh, J. (1993) Limitations of impedance plethysmography in the diagnosis of clinical suspected deep-vein thrombosis. Ann. Intern. Med. 118, 25–30.

    PubMed  CAS  Google Scholar 

  77. Ginserg, J. S., Wells, P. S., Hirsh, J., Panju, A. A., Patel, M. A., Malone, D. E., et al. (1994) Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. Arch. Intern. Med. 154, 1930–1933.

    Article  Google Scholar 

  78. Hull, R. D., Raskob, G. E., Pinco, G. F., et al. (1992) Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. N. Engl. J. Med. 326, 975–982.

    Article  PubMed  CAS  Google Scholar 

  79. Wells, P. S., Anderson, D. R., Bormani, J., Guy, F., Mitchell, M., Gray, L., et al. (1997) Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 350, 1795–1798.

    Article  PubMed  CAS  Google Scholar 

  80. Bigaroni, A., Perrier, A., and Bounameaux, H. (2000) Is clinical probability assessment of deep vein thrombosis by a score really standardized? Thromb. Haemostasis 83, 788–789.

    CAS  Google Scholar 

  81. Heijboer, H., Buller, H. R., Lensing, A. W. A., Turpie, A. G. G., Colly, L. P., and ten Cate, J. W. (1993) A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N. Engl. J. Med. 329, 1365–1369.

    Article  PubMed  CAS  Google Scholar 

  82. Weitz, J. I. (1997) Low-molecular-weight heparins. N. Engl. J. Med. 337, 688–698.

    Article  PubMed  CAS  Google Scholar 

  83. Lensing, A. W. A., Orins, M. H., Davidson, B. L., et al. (1995) Treatment of deep venous thrombosis with low-molecular-weight heparin: a meta-analysis. Arch. Intern. Med. 155, 601–607.

    Article  PubMed  CAS  Google Scholar 

  84. Siragusa, S., Cosmi, B., Piovella, F., et al. (1996) Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am. J. Med. 100, 269–277.

    Article  PubMed  CAS  Google Scholar 

  85. Leizorovicz, A., Simonneau, G., Decousus, H., et al. (1994) Comparison of efficacy and safety of low-molecular-weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis: a meta-analysis. Br. Med. J. 309, 299–304.

    Article  CAS  Google Scholar 

  86. Raschke, R. A., Reilly, B. M., Guidry, J. R., et al. (1993) The weight-based heparin dosing normogram compared with a “standard care” normogram. A randomized controlled trial. Ann. Intern. Med. 119, 874–881.

    PubMed  CAS  Google Scholar 

  87. de Groot, M. R., Büller, H. R., ten Cate, J. W., et al. (1998) Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital. Thromb. Haemostasis 80, 70–73.

    Google Scholar 

  88. Cruickshank, M. K., Lering, M. N., Hirsh, J., et al. (1991) A standard heparin normogram for the management of Heparin therapy. Arch. Intern. Med. 151, 333–337.

    Article  PubMed  CAS  Google Scholar 

  89. Campbell, N. R. C, Hull, R. D., Brant, R., et al. (1996) Aging and heparin-related bleeding. Arch. Intern. Med. 156, 857–860.

    Article  PubMed  CAS  Google Scholar 

  90. Zidane, M., Schram, M. T., Planken, E. W., et al. (2000) Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism. Arch. Intern. Med. 160, 2369–2373.

    Article  PubMed  CAS  Google Scholar 

  91. Nand, S., Wong, W., Yuen, B., et al. (1997) Heparin-induced thrombocytopenia with thrombosis: incidence analysis of risk factors and clinical outcomes in 108 consecutive patients treated at a single institution. Am. J. Hematol. 56, 12–16.

    Article  PubMed  CAS  Google Scholar 

  92. Hyers, et al. (2001) Antithrombotic therapy for venous thromboembolic disease. Chest 119, 176s–193s.

    Article  PubMed  CAS  Google Scholar 

  93. Dulitzki, M., Pauzner, R., Langevitz, P., et al. (1996) Low molecular weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet. Gynecol. 87, 380–383.

    Article  PubMed  CAS  Google Scholar 

  94. Orme, ĽE., Lewis, M., de Swiet, M., et al. (1977) May mothers given warfarin breast-feed their infants? BMJ 1, 1564–1565.

    Article  PubMed  CAS  Google Scholar 

  95. McKenna, R., Cole, E. R., and Vasan, V. (1983) Is warfarin sodium contraindicated in the lactating mother? J. Pediatr. 103, 325–327.

    Article  PubMed  CAS  Google Scholar 

  96. Dahlman, T. C. (1993) Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am. J. Obstet. Gynecol. 168, 1265–1270.

    PubMed  CAS  Google Scholar 

  97. Douketies, J. D., Ginsberg, J. S., Burrows, R. F., et al. (1996) The effects of long-term heparin therapy during pregnancy on bone density. Thromb. Haemostasis 75, 254–257.

    Google Scholar 

  98. Monreal, M., Lafoz, E., Olive, A., et al. (1994) Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb. Haemostasis 71, 7–11.

    CAS  Google Scholar 

  99. Muir, J. M., Hirsh, J., Weitz, J. I., et al. (1997) A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats. Blood 89, 3236–3242.

    PubMed  CAS  Google Scholar 

  100. Schwieder, G., Grimm, W., Siemens, H., Flor, B., Hilden, A., and Gmelin, E. (1995) Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT): a German multi-center trial. Thromb. Haemostasis 74, 1240–1243.

    CAS  Google Scholar 

  101. Grossman, C. and McPherson, S. (1999) Safety and efficacy of catheter-directed thrombolysis for iliofemoral venous thrombosis. Am. J. Roentgenol. 172, 667–672.

    CAS  Google Scholar 

  102. Mewissen, M. W., Seabrook, G. R., Meissner, M. H., Cynamon, J., Labropoulos, N., and Haughton, S. H. (1999) Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multi-center registry. Radiology 211, 39–49.

    PubMed  CAS  Google Scholar 

  103. Comerota, A. J., Throm, R. C, Matias, S. D., Haughton, S., and Mewisson, M. W. (2000) Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J. Vase. Surg. 32, 130–137.

    Article  CAS  Google Scholar 

  104. Tarry, W. C, Makhoul, R. G., Tisnado, J., Posner, M. P., Sober, M., and Lee, H. M. (1994) Catheter-directed thrombolysis following vena cava filtration for severe deep venous thrombosis. Ann. Vase. Surg. 8, 583–590.

    Article  CAS  Google Scholar 

  105. Patel, N. H., Plorde, J. J., and Meisner, M. (1998) Catheter directed thrombolysis in the treatment of phlegmasia cerulea dolens. Ann. Vase. Surg. 12, 471–475.

    Article  CAS  Google Scholar 

  106. Centeno, R. F., Nguyen, A. H., Ketterer, C., Stiller, G., Chait, A., and Fallahnejad, M. (1999) An alternative approach: antegrade catheter-directed thrombolysis in a case of phlegmasia cerulea dolens. Am. Surg. 65, 229–231.

    PubMed  CAS  Google Scholar 

  107. Arnesen, H., Hoiseth, A., and Ly, B. (1982) Streptokinase or heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med. Scand. 211, 65–68.

    Article  PubMed  CAS  Google Scholar 

  108. Ng, C. M. and Rivera, J. O. (1998) Meta-analysis of streptokinase and heparin in deep vein thrombosis. Am. J. Health Syst. Pharm. 55, 1995–2001.

    PubMed  CAS  Google Scholar 

  109. Goldhaber, S. Z., Hirsch, D. R., MacDougall, R. C, Polak, J. F., and Creager, M. A. (1996) Bolus recombinant urokinase versus heparin in deep vein thrombosis: a randomized controlled trial. Am. Heart J. 132, 314–318.

    Article  PubMed  CAS  Google Scholar 

  110. Goldhaber, S. Z., Meyerovits, M. F., Green, D., Vogelzang, R. L., Citrin, P., and Heit, J. (1990) Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am. J. Med. 88, 235–240.

    Article  PubMed  CAS  Google Scholar 

  111. Turpie, A. G. G., Levine, M., Hirsh, J., Ginsberg, J. S., Cruikshank, M., and Jay, R. (1990) Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis: results of a randomized trial. Chest 97, 1728–1758.

    Google Scholar 

  112. Arnesen, H., Hoiseth, A., and Ly, B. (1982) Streptokinase or heparin in the treatment of deep vein thrombosis: follow-up results of a prospective trial. Acta Med. Scand. 211, 65.

    Article  PubMed  CAS  Google Scholar 

  113. Johanson, L., Nylander, G., Hedner, U., et al. (1979) Comparison of streptokinase with heparin: late results in the treatment of deep vein thrombosis. Acta Med. Scand. 206, 93–98.

    Article  Google Scholar 

  114. Watz, R. and Savidge, G. F. (1979) Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. Acta Med. Scand. 205, 293–298.

    Article  PubMed  CAS  Google Scholar 

  115. Kakkar, V. V. and Lawrence, D. (1985) Hemodynamic and clinical assessment after therapy of acute deep vein thrombosis. Am. J. Surg. 10, 54–63.

    Google Scholar 

  116. Prandoni, P., Lensing, A. W. A., Cogo, A., et al. (1996) The long-term clinical course of acute deep venous thrombosis. Ann. Intern. Med. 125, 1–7.

    PubMed  CAS  Google Scholar 

  117. Stewart, J. R. and Greenfield, L. J. (1982) Transvenous vena caval filtration and pulmonary embolectomy. Surg. Clin. North Am. 62, 411–430.

    PubMed  CAS  Google Scholar 

  118. Greenfield, L. J. and Langham, M. R. (1984) Surgical approaches to thromboembolism. Br. J. Surg. 71, 968–970.

    Article  PubMed  CAS  Google Scholar 

  119. Dorfman, G. S. (1990) Percutaneous inferior vena caval filters. Radiology 174, 987–992.

    PubMed  CAS  Google Scholar 

  120. Leach, T. A., Pastena, J. A., Swan, K. G., et al. (1994) Surgical prophylaxis for pulmonary embolism. Am. Surg. 60, 292–295.

    PubMed  CAS  Google Scholar 

  121. Linsenmaier, U., Rieger, J., Schenk, F., et al. (1998) Indications, management, and complications of temporary inferior vena cave filters. Cardiovasc. Interv. Radiol. 21, 464–469.

    Article  CAS  Google Scholar 

  122. Spence, L. K., Gironta, M. G., Malde, H. M., et al. (1999) Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters. Radiology 210, 53–58.

    PubMed  CAS  Google Scholar 

  123. Meyer, G., Tamisier, D., Sors, H., et al. (1991) Pulmonary embolectomy a 20-year experience at one center. Ann. Thorac. Surg. 51, 232–236.

    Article  PubMed  CAS  Google Scholar 

  124. Gray, H. H., Morgan, J. M., Paneth, M., et al. (1988) Pulmonary embolectomy for acte massive pulmonary embolism: an analysis of 71 cases. Br. Heart J. 60, 196–200.

    Article  PubMed  CAS  Google Scholar 

  125. Clarke, D. B. and Abrams, L. D. (1986) Pulmonary embolectomy: a 25-year experience. J. Thorac. Cardiovasc. Surg. 92, 442–445.

    PubMed  CAS  Google Scholar 

  126. Decousus, H., Leizorovicz, A., Parent, F., et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N. Engl. J. Med. 338, 409–415.

    Article  PubMed  CAS  Google Scholar 

  127. Greenfield, L. J. and Rutherford, R. B. (1999) Recommended reporting standards for vena caval filter placement and patient follow-up: Vena Caval Filter Consensus Conference. J. Vase. Interv. Radiol. 10, 1013–1019.

    Article  CAS  Google Scholar 

  128. Kruip, M. J. H., Slob, M. J., Schijen, J. H., van der Heul, C., Böller, H. (2002) Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism. Arch. Intern. Med. 162, 1631–1635.

    Article  PubMed  Google Scholar 

  129. Hull, R. D., Hirsh, J., Carter, C, et al. (1983) Pulmonary angiography, ventilation, lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann. Intern. Med. 98–891.

    Google Scholar 

  130. Hull, R. D., Hirsh, J., Carter, C., et al. (1985) Diagnostic value of ventilation-perfusion in patients with suspected pulmonary embolism and abnormal perfusion lung scans. Chest 88, 819.

    Article  PubMed  CAS  Google Scholar 

  131. PIOPED Investigatiors (1990) Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263, 2753.

    Article  Google Scholar 

  132. Gottsöter, A., Berg, A., Centergard, J., Frennby, B., Nirhov, N., Nyman, U. (2001) Clinically suspected pulmonary embolism: is it safe to withhold anticoagulation after a negative sCT? Eur. Radiol. 11, 65–72.

    Article  Google Scholar 

  133. Van Beck, E. J. R., Brouwers, E. M. J., Song, B., Stein, P., Oudkerk, M. (2001) Clinical validation of a normal pulmonary angiogram in patients with suspected pulmonary embolism a critical review. Clin. Radiol. 56, 838–842.

    Article  Google Scholar 

  134. Goldhaber, S. Z. LMWH in combination with a vitamin K antagonist (VKA).

    Google Scholar 

  135. Simonneau, G., Sors, H., Charbonnier, B, Page Y, Laaban J-P, Azarian R, et al. for the THSE Study Group. (1997) A comparison of low-molecular weight heparin with unfractionated heparin for acute pulmonary embolism. N. Engl. J. Med. 337, 663–669.

    Article  PubMed  CAS  Google Scholar 

  136. The Columbus Investigators. (1997) Low-molecular weight heparin in the treatment of patients with venous thromboembolism. N. Engl. J. Med. 337, 657–662.

    Article  Google Scholar 

  137. Ginsberg, J. S., Bates, S. M. (2003) Management of venous thromboembolism during pregnancy. J. Thrombos. Haemostas. 1, 1435–1442.

    Article  CAS  Google Scholar 

  138. Goldhaber (2001) Thrombolysis in pulmonary embolism, a debatable indication. Thromb. Haemostasis 86, 444–451.

    CAS  Google Scholar 

  139. Konstantinides, S., Geibel, A., Heusel, G., Heinrich, F., Kasper, W. (2002) for the Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. N. Engl. J. Med. 347, 1143–1150.

    Article  PubMed  CAS  Google Scholar 

  140. Konstantinides, S. (2003) Thrombolysis in submassive pulmonary embolism? Yes. J. Thromb. Haemostas. 1, 1127–1129.

    Article  CAS  Google Scholar 

  141. Dalen, J. E. (2003) Thrombolysis in submassive pulmonary embolism? No. J. Thrombos. Haemostas. 1, 1130–1132.

    Article  CAS  Google Scholar 

  142. Grifoni, S., Olivotto, I., Cecchini, P., Pieralli, F., Camaiti, A., Santoro, G., et al. (2000) Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 101, 2817–2822.

    PubMed  CAS  Google Scholar 

  143. Konstantinides, S., Geibel, A., Kasper, W., Olschewski, M., Blumel, L., and Just, H. (1998) Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 97, 1946–1951.

    PubMed  CAS  Google Scholar 

  144. Chartier, L., Bera, J., Delomez, M., Asseman, P., Beregi, J. P., Bauchart, J. J., et al. (1999) Free-floating thrombi in the right heart: diagnosis, management, and prognostic indices in 38 consecutive patients. Circulation 99, 2779–2783.

    PubMed  CAS  Google Scholar 

  145. Giannitsis, E., Muller-Bardorff, M., Kurowski, V., Weidtmann, B., Wiegand, U., Kampmann, M., et al. (2000) Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 102, 211–217.

    PubMed  CAS  Google Scholar 

  146. Tebbe, U., Graf, A., Kamke, W., et al. (1999) Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.Am. Heart J. 138, 39–44.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia

    Hikmat Abdel-Razeq

  2. King Abdul-Aziz University Hospital, Jeddah, Saudi Arabia

    Mohamad Qari & Omar Al-Amoudi

  3. Tawam Hospital, Al Ain, United Arab Emirates

    Jorgen Kristensen & Hussein Alizeidah

  4. Health Sciences Center, Kuwait University, Kuwait

    Faisal Al-Sayegh

  5. Rashid Hospital, Dubai, United Arab Emirates

    Mahmoud Marashi

  6. King Khalid University Hospital, Riyadh, Saudi Arabia

    Abdulaziz Alzeer

  7. King Faisal University, Alkhobar, Saudi Arabia

    Hatem Qutub

  8. King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia

    Abdel-Aziz Al-Humiadi

  9. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark

    Steen Husted

  10. Albany College of Pharmacy, Albany, NY

    Shaker A. Mousa

Authors
  1. Hikmat Abdel-Razeq
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamad Qari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jorgen Kristensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hussein Alizeidah
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Faisal Al-Sayegh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahmoud Marashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Abdulaziz Alzeer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Omar Al-Amoudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hatem Qutub
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Abdel-Aziz Al-Humiadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Steen Husted
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shaker A. Mousa
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the GCC Thrombosis Study Group

Editor information

Editors and Affiliations

  1. Albany College of Pharmacy, Albany, NY

    Shaker A. Mousa

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc.

About this protocol

Cite this protocol

Abdel-Razeq, H. et al. (2004). Guidelines for Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism. In: Mousa, S.A. (eds) Anticoagulants, Antiplatelets, and Thrombolytics. Methods In Molecular Medicine™, vol 93. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-658-4:267

Download citation

  • DOI: https://doi.org/10.1385/1-59259-658-4:267

  • Publisher Name: Springer, Totowa, NJ

  • Print ISBN: 978-1-58829-083-0

  • Online ISBN: 978-1-59259-658-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation